Global Vertebral Augmentation Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Vertebroplastic Device and Kyphoplastic Device.

By End-User;

Hospitals, Ambulatory Surgery Centers, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn154866619 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Vertebral Augmentation Market (USD Million), 2021 - 2031

In the year 2024, the Global Vertebral Augmentation Market was valued at USD 677.04 million. The size of this market is expected to increase to USD 978.35 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.4%.

Vertebral augmentation procedures, encompassing vertebroplasty and kyphoplasty, have emerged as crucial interventions in managing vertebral compression fractures (VCFs). These fractures often result from osteoporosis or metastatic tumors, leading to debilitating pain and functional impairment. As the global population ages and instances of osteoporosis-related fractures rise, the demand for effective vertebral augmentation solutions escalates.

Market dynamics within the global vertebral augmentation landscape are undergoing significant shifts, driven by technological advancements, expanding healthcare infrastructure, and increasing awareness about minimally invasive spine procedures. The market is witnessing a notable influx of novel biomaterials and sophisticated delivery systems, aimed at enhancing procedural efficacy and patient outcomes. Moreover, the growing preference for minimally invasive procedures, coupled with shorter hospital stays and quicker recovery times, is fueling the adoption of vertebral augmentation techniques worldwide.

Despite the promising growth trajectory, the vertebral augmentation market faces challenges such as stringent regulatory requirements, reimbursement issues, and the need for robust clinical evidence supporting the long-term efficacy and safety of these procedures. Addressing these challenges necessitates collaborative efforts among industry stakeholders, including manufacturers, healthcare providers, and regulatory bodies, to foster innovation, streamline regulatory pathways, and ensure broader access to these transformative interventions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By End-User
    3. Market Snapshot, By Region
  4. Global Vertebral Augmentation Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population Trends
        2. Technological Advancements
        3. Increasing Incidence of Vertebral Fractures
      2. Restraints
        1. High Cost of Procedures
        2. Risks Associated with Augmentation
        3. Limited Reimbursement Policies
      3. Opportunities
        1. Emerging Markets Penetration
        2. Advancements in Minimally Invasive Techniques
        3. Rising Demand for Non-surgical Treatments
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Compititive Rivalry
  5. Market Segmentation
    1. Global Vertebral Augmentation Market, By Product, 2021 - 2031 (USD Million)
      1. Vertebroplastic Device
      2. Kyphoplastic Device
    2. Global Vertebral Augmentation Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgery Centers
      3. Others
    3. Global Vertebral Augmentation Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic Plc
      2. Johnson & Johnson
      3. Alphatec Spine Inc.
      4. Stryker Corporation
      5. Globus Medical Inc.
      6. Merit Medical Systems Inc.
      7. BMK Global Medical Company
      8. IZI Medical Products LLC
      9. RONTIS
      10. Zavation
  7. Analyst Views
  8. Future Outlook of the Market